Jane Street
BBIO icon

Jane Street’s BridgeBio Pharma BBIO Stock Holding History

Jane Street’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$230M Sell
3,099,100
-317,900
-9% -$23M 0.03% 351
2025
Q4 		$261M Buy
3,417,000
+68,400
+2% +$4.49M 0.04% 285
2025
Q3 		$174M Sell
3,348,600
-222,400
-6% -$10.8M 0.03% 395
2025
Q2 		$154M Buy
3,571,000
+234,800
+7% +$8.54M 0.03% 343
2025
Q1 		$115M Buy
3,336,200
+1,154,600
+53% +$38.9M 0.03% 342
2024
Q4 		$59.9M Buy
2,181,600
+183,800
+9% +$4.75M 0.01% 610
2024
Q3 		$50.9M Buy
1,997,800
+122,700
+7% +$3.22M 0.01% 687
2024
Q2 		$47.5M Buy
1,875,100
+1,550,800
+478% +$42.4M 0.01% 714
2024
Q1 		$10M Sell
324,300
-184,300
-36% -$6.27M ﹤0.01% 1814
2023
Q4 		$20.5M Buy
508,600
+58,400
+13% +$1.75M 0.01% 1241
2023
Q3 		$11.9M Sell
450,200
-74,600
-14% -$2.12M ﹤0.01% 1596
2023
Q2 		$9.03M Buy
524,800
+209,600
+66% +$3.15M ﹤0.01% 2020
2023
Q1 		$5.23M Buy
315,200
+297,700
+1,701% +$3.47M ﹤0.01% 2373
2022
Q4 		$133K Sell
17,500
-71,700
-80% -$686K ﹤0.01% 7940
2022
Q3 		$887K Sell
89,200
-74,600
-46% -$775K ﹤0.01% 5621
2022
Q2 		$1.49M Sell
163,800
-17,500
-10% -$146K ﹤0.01% 4723
2022
Q1 		$1.84M Sell
181,300
-558,500
-75% -$5.73M ﹤0.01% 4909
2021
Q4 		$12.3M Buy
739,800
+636,700
+618% +$26.9M ﹤0.01% 1646
2021
Q3 		$4.83M Buy
103,100
+43,900
+74% +$2.35M ﹤0.01% 2791
2021
Q2 		$3.61M Buy
59,200
+2,300
+4% +$131K ﹤0.01% 3223
2021
Q1 		$3.5M Buy
56,900
+47,100
+481% +$3.08M ﹤0.01% 2959
2020
Q4 		$697K Buy
+9,800
New +$473K ﹤0.01% 5227
2020
Q3 		– Sell
-35,600
Closed -$1.16M – 7140
2020
Q2 		$1.16M Buy
+35,600
New +$1.08M ﹤0.01% 3854

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's BBIO Position: Q1 2026 in Review

Jane Street increased its BridgeBio Pharma (BBIO) stake by 414% in Q1 2026, buying an estimated $103M and bringing the position to 1,757,672 shares worth $131M. The position accounts for 0.02% of the portfolio, ranked #532.

Jane Street first reported a position in BBIO in Q2 2020 and has held it in 24 quarters since. 458 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Jane Street held 1,757,672 shares of BridgeBio Pharma worth $131M as of Q1 2026.
  • Jane Street bought 1,415,877 BridgeBio Pharma shares in Q1 2026, an estimated $103M.
  • BridgeBio Pharma made up 0.02% of Jane Street's portfolio in Q1 2026, its #532 holding.
  • Jane Street first reported a position in BridgeBio Pharma in Q2 2020 and has held it in 24 quarters since.
  • 458 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.